627 related articles for article (PubMed ID: 30809720)
1. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
[TBL] [Abstract][Full Text] [Related]
2. Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
Paech D; Windschuh J; Oberhollenzer J; Dreher C; Sahm F; Meissner JE; Goerke S; Schuenke P; Zaiss M; Regnery S; Bickelhaupt S; Bäumer P; Bendszus M; Wick W; Unterberg A; Bachert P; Ladd ME; Schlemmer HP; Radbruch A
Neuro Oncol; 2018 Nov; 20(12):1661-1671. PubMed ID: 29733378
[TBL] [Abstract][Full Text] [Related]
3. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
Joo B; Han K; Ahn SS; Choi YS; Chang JH; Kang SG; Kim SH; Zhou J; Lee SK
Eur Radiol; 2019 Dec; 29(12):6643-6652. PubMed ID: 31175415
[TBL] [Abstract][Full Text] [Related]
4. Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.
Meissner JE; Korzowski A; Regnery S; Goerke S; Breitling J; Floca RO; Debus J; Schlemmer HP; Ladd ME; Bachert P; Adeberg S; Paech D
J Magn Reson Imaging; 2019 Oct; 50(4):1268-1277. PubMed ID: 30864193
[TBL] [Abstract][Full Text] [Related]
5. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
6. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
[TBL] [Abstract][Full Text] [Related]
8. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
[TBL] [Abstract][Full Text] [Related]
9. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.
Kroh F; von Knebel Doeberitz N; Breitling J; Maksimovic S; König L; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Magn Reson Med; 2023 Oct; 90(4):1569-1581. PubMed ID: 37317562
[TBL] [Abstract][Full Text] [Related]
10. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
Park JE; Kim HS; Park SY; Jung SC; Kim JH; Heo HY
Radiology; 2020 May; 295(2):397-406. PubMed ID: 32154775
[TBL] [Abstract][Full Text] [Related]
11. Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
Regnery S; Adeberg S; Dreher C; Oberhollenzer J; Meissner JE; Goerke S; Windschuh J; Deike-Hofmann K; Bickelhaupt S; Zaiss M; Radbruch A; Bendszus M; Wick W; Unterberg A; Rieken S; Debus J; Bachert P; Ladd M; Schlemmer HP; Paech D
Oncotarget; 2018 Jun; 9(47):28772-28783. PubMed ID: 29983895
[TBL] [Abstract][Full Text] [Related]
12. CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T.
von Knebel Doeberitz N; Kroh F; Breitling J; König L; Maksimovic S; Graß S; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Radiother Oncol; 2023 Jul; 184():109694. PubMed ID: 37150450
[TBL] [Abstract][Full Text] [Related]
13. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
[TBL] [Abstract][Full Text] [Related]
14. Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma.
Zaiss M; Windschuh J; Goerke S; Paech D; Meissner JE; Burth S; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Ladd ME; Bachert P; Radbruch A
Magn Reson Med; 2017 Jan; 77(1):196-208. PubMed ID: 26845067
[TBL] [Abstract][Full Text] [Related]
15. Direct saturation-corrected chemical exchange saturation transfer MRI of glioma: Simplified decoupling of amide proton transfer and nuclear overhauser effect contrasts.
Yuwen Zhou I; Wang E; Cheung JS; Lu D; Ji Y; Zhang X; Fulci G; Sun PZ
Magn Reson Med; 2017 Dec; 78(6):2307-2314. PubMed ID: 29030880
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
[TBL] [Abstract][Full Text] [Related]
17. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
18. Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T.
Goerke S; Soehngen Y; Deshmane A; Zaiss M; Breitling J; Boyd PS; Herz K; Zimmermann F; Klika KD; Schlemmer HP; Paech D; Ladd ME; Bachert P
Magn Reson Med; 2019 Aug; 82(2):622-632. PubMed ID: 30927313
[TBL] [Abstract][Full Text] [Related]
19. 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T.
Wu Y; Wood TC; Arzanforoosh F; Hernandez-Tamames JA; Barker GJ; Smits M; Warnert EAH
MAGMA; 2022 Feb; 35(1):63-73. PubMed ID: 34994858
[TBL] [Abstract][Full Text] [Related]
20. Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.
Zhang J; Zhu W; Tain R; Zhou XJ; Cai K
Mol Imaging Biol; 2018 Aug; 20(4):623-631. PubMed ID: 29313159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
